LENALIDOMIDE
These highlights do not include all the information needed to use LENALIDOMIDE CAPSULES safely and effectively. See full prescribing information for LENALIDOMIDE . LENALIDOMIDE capsules, for oral useInitial U.S. Approval: 2005
adee5af1-c9ab-c0c7-e400-dea7d2a0d4be
HUMAN PRESCRIPTION DRUG LABEL
Mar 6, 2023
Alvogen, Inc.
DUNS: 008057330
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lenalidomide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Lenalidomide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Lenalidomide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Lenalidomide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Lenalidomide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Lenalidomide
Product Details
FDA regulatory identification and product classification information